Third, as we focused on and examined EGFR mutation‐positive adenocarcinomas, it will also be necessary to study EGFR mutation‐negative specimens before any conclusion can be generalized to all lung adenocarcinomas. The gene discussed is EGFR; the disease is lung adenocarcinoma.